Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Advances in Neurology
|
November 22, 2002
Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
Stephen J Kish
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 26, 2003
What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
Stephen J Kish
Lancet (London, England)
|
June 6, 2002
Effects of MDMA (ecstasy) use and abstention on serotonin neurons
Stephen J Kish
Pharmacology, Biochemistry, and Behavior
|
March 13, 2002
How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
Stephen J Kish
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
June 19, 2008
Pharmacologic mechanisms of crystal meth
Stephen J Kish
Brain : a Journal of Neurology
|
November 23, 2014
Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia
Yoshiaki Furukawa, Stephen J Kish
International Review of Neurobiology
|
January 7, 2003
Mitochondria in Alzheimer's disease
Russell H Swerdlow, Stephen J Kish
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 28, 2020
Professor Oleh Hornykiewicz, MD (1926-2020): Remembering the Father of the Modern Treatment of Parkinson's Disease and the Man
Ali H Rajput, Stephen J Kish
Journal of Neurochemistry
|
December 13, 2005
Identification of a noradrenaline-rich subdivision of the human nucleus accumbens
Junchao Tong, Oleh Hornykiewicz, Stephen J Kish
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 6, 2012
Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms
Christian Pifl, Stephen J Kish, Oleh Hornykiewicz
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Advances in Neurology
|
November 22, 2002
Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
Stephen J Kish
Movement Disorders : Official Journal of the Movement Disorder Society
|
November 26, 2003
What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?
Stephen J Kish
Lancet (London, England)
|
June 6, 2002
Effects of MDMA (ecstasy) use and abstention on serotonin neurons
Stephen J Kish
Pharmacology, Biochemistry, and Behavior
|
March 13, 2002
How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
Stephen J Kish
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
June 19, 2008
Pharmacologic mechanisms of crystal meth
Stephen J Kish
Brain : a Journal of Neurology
|
November 23, 2014
Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia
Yoshiaki Furukawa, Stephen J Kish
International Review of Neurobiology
|
January 7, 2003
Mitochondria in Alzheimer's disease
Russell H Swerdlow, Stephen J Kish
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 28, 2020
Professor Oleh Hornykiewicz, MD (1926-2020): Remembering the Father of the Modern Treatment of Parkinson's Disease and the Man
Ali H Rajput, Stephen J Kish
Journal of Neurochemistry
|
December 13, 2005
Identification of a noradrenaline-rich subdivision of the human nucleus accumbens
Junchao Tong, Oleh Hornykiewicz, Stephen J Kish
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 6, 2012
Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms
Christian Pifl, Stephen J Kish, Oleh Hornykiewicz
Page
of 12